[1] Ch'ng C L, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut, 2002, 51(6): 876-880.
[2] Mitchell A L, Ovadia C, Syngelaki A, et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study. Bjog, 2021, 128(10): 1635-1644.
[3] Westbrook R H, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol, 2016, 64(4): 933-945.
[4] Fejzo MS, Sazonova OV, Sathirapongsasuti JF, et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun, 2018, 9(1): 1178.
[5] Gaba N, Gaba S. Study of Liver Dysfunction in Hyperemesis Gravidarum. Cureus, 2020, 12(6): e8709.
[6] Nana M, Tydeman F, Bevan G, et al. Hyperemesis gravidarum is associated with increased rates of termination of pregnancy and suicidal ideation: results from a survey completed by >5000 participants. Am J Obstet Gynecol, 2021, 224(6): 629-631.
[7] Whitehouse AJO, Alvares GA, Cleary D, et al. Symptom severity in autism spectrum disorder is related to the frequency and severity of nausea and vomiting during pregnancy: a retrospective case-control study. Mol Autism, 2018, 9: 37.
[8] Sarkar M, Brady C W, Fleckenstein J, et al. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology, 2021, 73(1): 318-365.
[9] Kaplan YC, Richardson JL, Keskin-Arslan E, et al. Use of ondansetron during pregnancy and the risk of major congenital malformations: A systematic review and meta-analysis. Reprod Toxicol, 2019, 86: 1-13.
[10] Cauldwell M, Mackie FL, Steer PJ, et al. Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study. Bjog, 2020, 127(7): 876-884.
[11] Rahim MN, Theocharidou E, Yen Lau KG, et al. Safety and efficacy of in?vitro fertilisation in patients with chronic liver disease and liver transplantation recipients. J Hepatol, 2021, 74(6): 1407-1415.
[12] Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet, 2019, 393(10174): 899-909.
[13] Vasavan T, Deepak S, Jayawardane IA, et al. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations. J Hepatol, 2021, 74(5): 1087-1096.
[14] Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet, 2019, 394(10201): 849-860.
[15] Ovadia C, Sajous J, Seed PT, et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol, 2021, 6(7): 547-558.
[16] Ovadia C, Williamson C. Intrahepatic cholestasis of pregnancy: Recent advances. Clin Dermatol, 2016, 34(3): 327-334.
[17] Ovadia C, L?vgren-Sandblom A, Edwards L A, et al. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action. J Clin Apher, 2018, 33(6): 638-644.
[18] Turro E, Astle WJ, Megy K, et al. Whole-genome sequencing of patients with rare diseases in a national health system. Nature, 2020, 583(7814): 96-102.
[19] Reichert MC, Lammert F. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum. Semin Liver Dis, 2018, 38(4): 299-307.
[20] Meher S, Duley L, Hunter K, et al. Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis. Am J Obstet Gynecol, 2017, 216(2): 121-128.e2.
[21] Von Salmuth V, Van Der Heiden Y, Bekkers I, et al. The role of hepatic sinusoidal obstruction in the pathogenesis of the hepatic involvement in HELLP syndrome: Exploring the literature. Pregnancy Hypertens, 2020, 19: 37-43.
[22] Gomez-Tolub R, Rabinovich A, Kachko E, et al. Placental abruption as a trigger of DIC in women with HELLP syndrome: a population-based study. J Matern Fetal Neonatal Med, 2022, 35(17): 3259-3269.
[23] Tolunay HE, Kahraman NC, Varli EN, et al. Can First-trimester AST to Platelet Ratio Index Scores Predict HELLP Syndrome?. J Coll Physicians Surg Pak, 2021, 31(2): 188-192.
[24] Roberge S, Nicolaides K, Demers S, et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol, 2017, 216(2): 110-120.e6.
[25] Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol, 2008, 112(2 Pt 1): 359-372.
[26] Nelson DB, Byrne JJ, Cunningham FG. Acute Fatty Liver of Pregnancy. Clin Obstet Gynecol, 2020, 63(1): 152-164.
[27] Chang L, Wang M, Liu H, et al. Pregnancy outcomes of patients with acute fatty liver of pregnancy: a case control study. BMC Pregnancy Childbirth, 2020, 20(1): 282.
[28] Natarajan SK, Thangaraj KR, Eapen CE, et al. Liver injury in acute fatty liver of pregnancy: possible link to placental mitochondrial dysfunction and oxidative stress. Hepatology, 2010, 51(1): 191-200.
[29] Joueidi Y, Peoc'h K, Le Lous M, et al. Maternal and neonatal outcomes and prognostic factors in acute fatty liver of pregnancy. Eur J Obstet Gynecol Reprod Biol, 2020, 252: 198-205.
[30] Byrne JJ, Seasely A, Nelson DB, et al. Comparing acute fatty liver of pregnancy from hemolysis, elevated liver enzymes, and low platelets syndrome. J Matern Fetal Neonatal Med, 2022, 35(7): 1352-1362.
[31] Walayat S, Shoaib H, Asghar M, et al. Role of N-acetylcysteine in non-acetaminophen-related acute liver failure: an updated meta-analysis and systematic review. Ann Gastroenterol, 2021, 34(2): 235-240.
[32] Wu Z, Huang P, Gong Y, et al. Treating acute fatty liver of pregnancy with artificial liver support therapy: Systematic review. Medicine (Baltimore), 2018, 97(38): e12473. |
